Literature DB >> 22682427

An autopsy case of sudden unexpected nocturnal death syndrome with R1193Q polymorphism in the SCN5A gene.

Aya Matsusue1, Masayuki Kashiwagi, Kenji Hara, Brian Waters, Tomoko Sugimura, Shin-ichi Kubo.   

Abstract

SCN5A (sodium channel, voltage-gated, type V, alpha subunit) gene encodes the cardiac sodium channel, a member of the voltage-gated sodium channel family. SCN5A mutations have been associated with a variety of inherited arrhythmias, including long QT syndrome and Brugada syndrome. We report an autopsy case of sudden unexpected nocturnal death syndrome. A man in his thirties died at night while sleeping. At autopsy, no traumatic injury, disease or drug intake was observed as a possible cause of death. We examined mutations in the SCN5A gene and identified a heterozygous mutation causing an R1193Q amino acid substitution. It was reported that the R1193Q polymorphism in the SCN5A gene destabilizes channel inactivation and may be a risk factor for Brugada and long QT syndrome. It may be considered that the cause of death in this case was sudden cardiac death.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22682427     DOI: 10.1016/j.legalmed.2012.04.009

Source DB:  PubMed          Journal:  Leg Med (Tokyo)        ISSN: 1344-6223            Impact factor:   1.376


  2 in total

1.  SCN5A Genetic Polymorphisms Associated With Increased Defibrillator Shocks in Brugada Syndrome.

Authors:  Pattarapong Makarawate; Narumol Chaosuwannakit; Suda Vannaprasaht; Dujdao Sahasthas; Seok Hwee Koo; Edmund Jon Deoon Lee; Wichittra Tassaneeyakul; Hector Barajas-Martinez; Dan Hu; Kittisak Sawanyawisuth
Journal:  J Am Heart Assoc       Date:  2017-06-05       Impact factor: 5.501

2.  Lack of modulatory effect of the SCN5A R1193Q polymorphism on cardiac fast Na+ current at body temperature.

Authors:  Masayoshi Abe; Koshi Kinoshita; Kenta Matsuoka; Takahito Nakada; Kimiaki Miura; Yukiko Hata; Naoki Nishida; Toshihide Tabata
Journal:  PLoS One       Date:  2018-11-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.